Spec. Buğra Sağlam, M.D.

Articles Published in Peer-Reviewed Journals:

• Cömert, Pinar, Murat Albayrak, Abdulkerim Yildiz, Osman Sahin, Cigdem Pala Ozturk, Senem Maral, Gursel Gunes, Hacer Berna Afacan Ozturk, and Bugra Saglam. “An acute transverse myelitis attack after autologous stem cell transplantation: A rare case.” Transfusion and Apheresis Science 58, no. 3 (2019): 341-343.

• Comert, P., M. Albayrak, A. Yildiz, M. Tiglioglu, B. Saglam, and O. Sahin. “Richter transformation in patients with chronic lymphocytic leukemia: three cases and literature review.” In LEUKEMIA RESEARCH, vol. 85, pp. S57-S57. Pergamon-Elsevier Science Ltd, Oxford, England, 2019.

• Saglam, B., M. Albayrak, A. Yildiz, M. Tiglioglu, P. Comert, C. Pala Ozturk, S. Maral, H. Afacan Ozturk, and O. Sahin. “Localized skin edema associated with ATRA in a patient with acute promyelocytic leukemia: a case report.” Leukemia Research 85 (2019): S56-S57.

• Akyol, Pinar, Abdulkerim Yildiz, Murat Albayrak, Murat Yildirim, Mesut Tiglioglu, Bugra Saglam, Senem Maral, Hacer Berna Afacan Ozturk, Meltem Ayli, and Osman Sahin. “Clinical features and possible prognostic factors in patients with Marginal Zone Lymphoma: Retrospective analysis from two centers.” (2021).

• Aras, M. Reis, M. Albayrak, B. Saglam, S. Maral, H. Afacan Ozturk, and A. Yildiz. “Case of atrial fibrillation secondary to ibrutinib and resulting in death.” Leukemia Research 85 (2019): S45-S46.

• Malkan, Umit Yavuz, Murat Albayrak, Hacer Berna Ozturk, Merih Reis Aras, Bugra Saglam, and Kutsal Dogan. “A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura.” Case Reports in Oncology 13, no. 3 (2020): 1368-1372.

• Saglam, Bugra, Murat Albayrak, Ali Acar, Abdulkerim Yildiz, Senem Maral, Mesut Tiglioglu, Ismet Battal, Esra Nur Sahin, and Arif Kus. “Q fever as a rare cause of hemophagocytic lymphohistiocytosis: case report.” Transfusion and Apheresis Science 59, no. 4 (2020): 102747.

• Saglam, Bugra, Murat Albayrak, Abdulkerim Yildiz, Pinar Akyol, Cigdem Pala Ozturk, Senem Maral, Hacer Berna Afacan Ozturk, Mesut Tiglioglu, and Osman Sahin. “A Rare Entity in Chronic Myelocytic Leukemia: Coexistence of BCR ABL1 Translocation and JAK2 V617F Mutation. Case Report.” SN Comprehensive Clinical Medicine (2020): 1-3.

• Erkurt, Mehmet Ali, Fehmi Hindilerden, Omer Ekinci, Jale Yildiz, Mehmet Sinan Dal, Metin Bagci, Tuba Hacibekiroglu, et al. “An Experience on Pomalidomide in Patients within Relapsed/Refractory Multiple Myeloma-A Multicenter Study in Turkey.” Journal of Pharmaceutical Research International (2020): 92-98.

• Akyol, Pinar, Murat Albayrak, Senem Maral, Filiz Canpolat, Hacer Berna Afacan Ozturk, Bugra Saglam, and Mesut Tiglioglu. “Diffuse large B cell lymphoma progression with skin involvement: A case report.” Journal of Tissue Viability 29, no. 3 (2020): 216-217.

• Tiglioglu, Mesut, Pinar Akyol, Bugra Saglam, Merih Reis Aras, Hacer Berna Afacan Ozturk, Abdulkerim Yildiz, and Murat Albayrak. “Thrombocytopenia due to rivaroxaban: A rare adverse effect.” Transfusion and Apheresis Science 59, no. 6 (2020): 102883.

• Tiglioglu, Mesut, Murat Albayrak, Servihan Dogan, Fatma Yilmaz, Pinar Akyol, Bugra Saglam, Merih Reis Aras, Abdulkerim Yildiz, Hacer Berna Afacan Ozturk, and Imdat Dilek. “Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis.” Leukemia & Lymphoma (2021): 1-7.

• Tiglioglu, Mesut, Pinar Tiglioglu, Abdulkerim Yildiz, Merih Reis Aras, Bugra Saglam, Hacer Berna Afacan Ozturk, Aysegul Adabag, Murat Albayrak. “Leukocytoclastic vasculitis related to ruxolitinib treatment: A rare side effect.” Clinical Pharmacy and Therapeutics Journal (2021).

• Akyol, Pinar, Abdulkerim Yildiz, Murat Albayrak, Hacer Berna Afacan Ozturk, Senem Maral, Merih Reis Aras, Fatma Yilmaz, Bugra Saglam, Mesut Tiglioglu, and Umit Yavuz Malkan. “Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients.” Gülhane Medical Journal 63, no. 2 (2021): 117.

• Akyol, Pinar, Abdulkerim Yildiz, Murat Albayrak, Murat Yildirim, Mesut Tiglioglu, Bugra Saglam, Senem Maral, Hacer Berna Afacan Ozturk, Meltem Ayli, and Osman Sahin. “Clinical features and possible prognostic factors in patients with Marginal Zone Lymphoma: Retrospective analysis from two centers.” (2021).

• Akyol, Pinar, Abdulkerim Yildiz, H. Afacan Ozturk, Senem Maral, Merih Reis Aras, Fatma Yilmaz, Bugra Saglam, Mesut Tiglioglu, and Murat Albayrak. “Disease and clinical characteristics of patients with chronic myeloproliferative neoplasms: 11-year single center experience.” Hematology, Transfusion and Cell Therapy 42 (2020): 43.

• Saglam, Bugra, Abdulkerim Yildiz, Bugra Kaya, and Kultigin Turkmen. “The predictive value of FDG PET/CT in the evaluation of bone marrow involvement in lymphoma patients.” Acta Oncologica Turcica 54, no. 3: 0-0.

  Afacan Ozturk, Hacer Berna, Murat Albayrak, Abdulkerim Yildiz, Senem Maral, Pinar Comert, Bugra Saglam, and Mesut Tiglioglu. “The Prognostic Value of Blood Count Parameters in Patients with Diffuse Large B Cell Lymphoma.” Akdeniz Medical Journal 7, no. 1 (2021): 65-70.

• Aras, Merih Reis, Murat Albayrak, Abdulkerim Yildiz, Senem Maral, Hacer Berna Afacan Ozturk, Pinar Akyol, Mesut Tiglioglu, Bugra Saglam, and Fatma Yilmaz. “The Predictive Value of FDG-PET/CT in Assessing Bone Marrow Involvement in Hodgkin Lymphoma Patients; A Single Center Experience.” Acta Oncologica Turcica 54, no. 3 (2021): 352-357.

• Aras, Merih Reis, Mehlika Panpalli Ates, Murat Albayrak, Hacer Berna Afacan Ozturk, Abdulkerim Yildiz, Fatma Yilmaz, Bugra Saglam, and Selim Selcuk Comoglu. “Therapeutic Plasma Exchange in Neurological Disorders: A 9-year Experience.” International Journal of Hematology and Oncology 33, no. 1 (2022): 202-208.

• Yilmaz, Fatma, Murat Albayrak, Pinar Tiglioglu, Mesut Tiglioglu, Bugra Saglam, Merih Reis Aras, Senem Maral, and Hacer Berna Afacan Ozturk. “Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment.” Journal of Oncology Pharmacy Practice 28, no. 3 (2022): 725-728.

• Aras, Merih Reis, Fatma Yilmaz, Mesut Tiglioglu, Bugra Saglam, Busra Yuzgenc, Hacer Berna Afacan Ozturk, Umit Yavuz Malkan, and Murat Albayrak. “The Prognostic Significance of Prognostic Nutritional Index in Diffuse Large B Cell Lymphoma Patients.” International Journal of Hematology and Oncology 33, no. 1 (2022): 008-013.

• Tiglioglu, Pinar, Murat Albayrak, Hacer Berna Afacan Ozturk, Mesut Tiglioglu, Bugra Saglam, Merih Reis, Fatma Yilmaz, Senem Maral, and Umit Yavuz Malkan. “Single Centre Experience: Benign and Malignant Hematological Patients with COVID-19.” Sağlık Akademisi Kastamonu 7, no. Covid-19 Supplement (2022): 108-115.

• Yilmaz, Fatma, Murat Albayrak, Abdulkerim Yildiz, Hacer Berna Afacan Ozturk, Senem Maral, Pinar Akyol, Merih Reis, Bugra Saglam, and Mesut Tiglioglu. “Does blood type have an effect on the course of COVID-19?” Sağlık Akademisi Kastamonu 7, no. Covid-19 Supplement (2022): 100-107.

• Aras, M. R., M. Albayrak, A. Yildiz, S. Maral, H. B. Afacan Ozturk, P. Tiglioglu, M. Tiglioglu, B. Saglam, and F. Yilmaz. “The prognostic significance of blood counts in patients with Hodgkin lymphoma.” Nigerian Journal of Clinical Practice 25, no. 8 (2022): 1332-1337.

• Tiglioglu, Mesut, Murat Albayrak, Abdulkerim Yildiz, Pinar Tiglioglu, Bugra Saglam, Fatma Yilmaz, Merih Reis Aras, Umit Yavuz Malkan, and Hacer Berna Afacan Ozturk. “Analysis of factors predicting the efficacy of Imatinib in patients with Chronic Myeloid Leukemia: A retrospective analysis.” Medical Science and Discovery 9, no. 9 (2022): 532-536.

• Saglam, Bugra, Murat Albayrak, Abdulkerim Yildiz, Pinar Tiplioglu, Mesut Tiglioglu, Merih Reis Aras, Fatma Yilmaz, and Hacer Berna Afacan Ozturk. “The relationship between ferritin level and thrombosis in patients with diffuse large B-cell lymphoma.” Hematology, Transfusion and Cell Therapy 44 (2022): S31.

• Zeynelgil, Esra, Ozlem Dogan, Bugra Saglam, and A. S. I. L. Mehmet. “Assessment of serum cyanocobalamin level and its importance in patients with hematological malignancies.” Turkish Journal of Clinics and Laboratory 14, no. 2 (2023): 270-273.

• Yilmaz, F., Saglam, B., Aras, M. R., Ozturk, H. B. A., Caykoylu, H. H., Gulcicek, A. M. Y., … & Albayrak, M. (2023). “In the management of febrile neutropenia; evaluation of the factors affecting the length of hospital stay.” Turkish Journal of Clinics and Laboratory, 14(3), 587-591.

• Saglam, B., Albayrak, M., Yildiz, A., Tiglioglu, P., Tiglioglu, M., Aras, M. R., … & Ozturk, H. B. A. (2023). “The prognostic impact of comorbidity, nutritional and performance status on patients with diffuse large B cell lymphoma.” Nigerian Journal of Clinical Practice, 26(10), 1512-1518.